Cargando…
miR-129-5p inhibits prostate cancer proliferation via targeting ETV1
BACKGROUND: Prostate cancer is one of the most commonly diagnosed diseases in males. METHODS: RT-qPCR was used to detect miR-129-5p expression in tumor tissues and adjacent normal tissues from patients with prostate cancer. The cell proliferation assay and colony forming assay were used to study the...
Autores principales: | Gao, Ge, Xiu, Dianhui, Yang, Bin, Sun, Daju, Wei, Xin, Ding, Youpeng, Ma, Yanan, Wang, Zhixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512784/ https://www.ncbi.nlm.nih.gov/pubmed/31190859 http://dx.doi.org/10.2147/OTT.S183435 |
Ejemplares similares
-
Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging miR-216a-5p
por: Yang, Bin, et al.
Publicado: (2018) -
TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a
por: Yang, Bin, et al.
Publicado: (2018) -
miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2016) -
AB066. MiR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2017) -
Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials
por: Liu, Feng, et al.
Publicado: (2018)